BRT provides in vivo models to evaluate hypersensitivity and allergic responses, with integrated immune assessments to support customized preclinical research programs.
BRT offers in vivo models to evaluate hypersensitivity responses and associated immune endpoints in customized preclinical studies.
BRT supports in vivo approaches for evaluating skin sensitization and irritancy as part of customized hypersensitivity research programs.
Hypersensitivity studies can be integrated with ex vivo and in vitro assessments to further characterize immune responses and treatment-related effects.
BRT works with clients to develop customized hypersensitivity and allergy studies based on specific research objectives, test articles, models, and immune response endpoints.
